Loading clinical trials...

PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00614705

PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia

This is a proof-of-concept study to determine if PH-797804 reduces neuropathic pain associated with post-herpetic neuralgia. Suitable patients will be randomized to receive either PH-797804 or placebo...

Lead sponsor: Pfizer•25 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 3

A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia

NCT00394901 · Neuralgia, Postherpetic

TERMINATEDPhase 2

A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

NCT00282763 · Neuralgia, Postherpetic

TERMINATEDPhase 2

Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)

NCT00245544 · Neuralgia, Postherpetic

COMPLETEDPhase 1

Neuropathic Pain Syndrome Patient Study (MK-0000-072)

NCT00570310 · Neuralgia, Postherpetic, Diabetic Neuropathy, and more

COMPLETEDPhase 2

A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)

NCT00160511 · Neuralgia, Postherpetic

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 16, 2011Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment80

Start dateApr 2008

Last updatedMay 16, 2011

Condition

Neuralgia, Postherpetic

Locations shown

Pfizer Investigational Site

Viña del Mar, Región de Valparaíso

Pfizer Investigational Site

Moscow

Pfizer Investigational Site

Saint Petersburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 16, 2011Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia

A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)

Neuropathic Pain Syndrome Patient Study (MK-0000-072)

A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)

Trial snapshot

Condition

Locations shown

For caregivers